Literature DB >> 30144219

Challenges in diagnosis and management of acquired factor XIII (FXIII) inhibitors.

Joan D Beckman1, Raj S Kasthuri1, Alisa S Wolberg2, Alice D Ma1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30144219      PMCID： PMC6390178          DOI： 10.1111/hae.13603

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  10 in total

1.  Detection of Factor XIII deficiency: data from multicentre exercises amongst UK NEQAS and PRO-RBDD project laboratories.

Authors:  I Jennings; S Kitchen; M Menegatti; R Palla; I Walker; M Makris; F Peyvandi
Journal:  Int J Lab Hematol       Date:  2017-04-13       Impact factor: 2.877

Review 2.  Acquired Factor XIII Inhibitor in Hospitalized and Perioperative Patients: A Systematic Review of Case Reports and Case Series.

Authors:  Kira J Tone; Tyler E James; Dean A Fergusson; Alan Tinmouth; Jason Tay; Marc T Avey; Shaun Kilty; Manoj M Lalu
Journal:  Transfus Med Rev       Date:  2016-04-22

3.  Factor XIII activity mediates red blood cell retention in venous thrombi.

Authors:  Maria M Aleman; James R Byrnes; Jian-Guo Wang; Reginald Tran; Wilbur A Lam; Jorge Di Paola; Nigel Mackman; Jay L Degen; Matthew J Flick; Alisa S Wolberg
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

Review 4.  Auto- and alloantibodies against factor XIII: laboratory diagnosis and clinical consequences.

Authors:  L Muszbek; K Pénzes; É Katona
Journal:  J Thromb Haemost       Date:  2018-03-23       Impact factor: 5.824

5.  Minimal factor XIII activity level to prevent major spontaneous bleeds.

Authors:  M Menegatti; R Palla; M Boscarino; P Bucciarelli; L Muszbek; E Katona; M Makris; F Peyvandi
Journal:  J Thromb Haemost       Date:  2017-08-17       Impact factor: 5.824

6.  Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking.

Authors:  James R Byrnes; Cédric Duval; Yiming Wang; Caroline E Hansen; Byungwook Ahn; Micah J Mooberry; Martha A Clark; Jill M Johnsen; Susan T Lord; Wilbur A Lam; Joost C M Meijers; Heyu Ni; Robert A S Ariëns; Alisa S Wolberg
Journal:  Blood       Date:  2015-08-31       Impact factor: 22.113

Review 7.  Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: A summary of 93 patients.

Authors:  Akitada Ichinose
Journal:  Blood Rev       Date:  2016-08-11       Impact factor: 8.250

8.  Alloantibody developed in a factor XIII A subunit deficient patient during substitution therapy; characterization of the antibody.

Authors:  K Pénzes; C Vezina; Z Bereczky; É Katona; M Kun; L Muszbek; G E Rivard
Journal:  Haemophilia       Date:  2015-08-07       Impact factor: 4.287

Review 9.  Acquired factor XIII deficiency: a therapeutic challenge.

Authors:  Françoise Boehlen; Alessandro Casini; Carlo Chizzolini; Behrouz Mansouri; Hans Peter Kohler; Verena Schroeder; Guido Reber; Philippe de Moerloose
Journal:  Thromb Haemost       Date:  2013-01-10       Impact factor: 5.249

Review 10.  Diagnosis and Management of Congenital and Acquired FXIII Deficiencies.

Authors:  László Muszbek; Éva Katona
Journal:  Semin Thromb Hemost       Date:  2016-04-12       Impact factor: 4.180
  10 in total
  5 in total

1.  Mechanistic rationale for factor XIII cotreatment in haemophilia.

Authors:  Joan D Beckman; Alisa S Wolberg
Journal:  Haemophilia       Date:  2019-10-02       Impact factor: 4.287

Review 2.  Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability.

Authors:  Alisa S Wolberg; Yaqiu Sang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-06-02       Impact factor: 10.514

3.  Acquired Factor XIII Deficiency Inducing Recurrent and Fatal Bleeding, Description of a Case.

Authors:  Pierpaolo Di Micco; Gualberto Gussoni; Filippo Pieralli; Mauro Campanini; Francesco Dentali; Andrea Fontanella
Journal:  J Blood Med       Date:  2020-01-30

4.  Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase Activity.

Authors:  Martina Leitner; Christian Büchold; Ralf Pasternack; Nikolaus B Binder; Gary W Moore
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

Review 5.  Factor XIII-A: An Indispensable "Factor" in Haemostasis and Wound Healing.

Authors:  Fahad S M Alshehri; Claire S Whyte; Nicola J Mutch
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.